Study to Assess Safety and Efficacy of Filgotinib, Lanraplenib and Tirabrutinib in Adults With Active Sjogren's Syndrome
Clinical trial NCT03100942 · COMPLETED
Trial details
- NCT number
- NCT03100942
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-01
- Primary completion
- 2019-01-10
- Enrollment
- 152
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.